Crossmark

Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial

Crossref DOI link: https://doi.org/10.1016/j.repc.2021.09.023

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Barati, Saghar http://orcid.org/0000-0002-5620-338X
Amini, Hossein http://orcid.org/0000-0002-6594-0760
Ahmadi, Zargham Hossein http://orcid.org/0000-0002-2982-9950
Dastan, Alireza

Sharif Kashani, Babak http://orcid.org/0000-0002-3400-489X
Eskandari, Raha

Dastan, Farzaneh
License Information

Text and Data Mining valid from 2023-02-01

Version of Record valid from 2022-10-07
More Information

This article is maintained by: Elsevier

Article Title: Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2021.09.023

Content Type: article

Copyright: © 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below